Impact of the year 2000 medicare policy change on older patient enrollment to cancer clinical trials

Journal of Clinical Oncology

Volumn 24, Issue 1, 2006, Pages 141-144

  Unger, Joseph M ^a   Coltman Jr , Charles A ^a   Crowley, John J ^a   Hutchins, Laura F ^a   Martino, Silvana ^a   Livingston, Robert B ^a   Macdonald, John S ^a   Blanke, Charles D ^a   Gandara, David R ^a   Crawford, E David ^a   Albain, Kathy S ^a  

^a SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CHILD; COLORECTAL CANCER; DEMOGRAPHY; ETHNICITY; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH SERVICE; HOSPITAL ADMISSION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT CARE; PATIENT PARTICIPATION; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; PROSTATE CANCER; RACE DIFFERENCE; SEX RATIO; UNITED STATES; CLINICAL TRIAL; ETHNOLOGY; NEOPLASM;

AGED; CLINICAL TRIALS; FEMALE; HUMANS; MALE; MEDICARE; NEOPLASMS;

EID: 33644847203     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.8928     Document Type: Article

References (14)

1. Hutchins LF, Unger JM, Crowley JJ, et al: Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341: 2061-2067, 1999
2. Trimble EL, Carter CL, Cain D, et al: Representation of older patients in cancer treatment trials. Cancer 74:2208-2214, 1994
3. Unger JM, Hutchins LF, Albain KS: Underrepresentation of elderly patients in cancer clinical trials: Causes and remedial strategies, in Balducci L, Lyman GH, Ershler WB, et al (eds): Comprehensive Geriatric Oncology (ed 2). New York, NY, Taylor & Francis, 2004, pp 259-274
4. Department of Health and Human Services: President Clinton takes new action to encourage participation in clinical trials. Medicare will reimburse for all routine patient care costs for those in clinical trials. White House Press Release. Washington, DC, Office of the Press Secretary, The White House, June 7, 2000. http://www.os.dhhs.gov/news/press/2000pres/20000607.html
5. Hesketh PJ, Chansky K, Lau DH, et al: Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: A Southwest Oncology Group phase II trial (S0027). J Clin Oncol 22:627, 2004 (suppl, abstr 7056)
6. Sundararajan V, Mitra N, Jacobson JS, et al: Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 136: 349-357, 2002
7. Hershman D, Jacobson JS, McBride R, et al: Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. Gynecol Oncol 94:540-549, 2004
8. Yee KW, Pater JL, Pho L, et al: Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier? J Clin Oncol 21: 1618-1623, 2003
9. Bennett CL, Adams JR, Knox KS, et al: Clinical trials: Are they a good buy? J Clin Oncol 19:4330-4339, 2001
10. Medicare: Medicare plan choices. http://www.medicare.gov/Choices/ Overview.asp.
11. Centers for Medicare and Medicaid Services: Medicare coverage: Clinical trials. Program memorandum. http://www.cms.hhs.gov/coverage/8d3.asp
12. American Society of Clinical Oncology: Concerns with clinical trial benefits under Medicare advantage. ASCO News. Policy Watch, July 26, 2004. http://web1.asco.org/ac/1,1003,_12-002163-00_18-0035183-00_19-0035186-00_20-001, 00.asp
13. American Society of Clinical Oncology: Letter, from Dean Gesme, Jr., MD, Chair, Clinical Practice Committee of the American Society of Clinical Oncology, to Mark A. McClellan, MD, PhD, Administrator for Centers for Medicare and Medicaid Services. July 27, 2004. http://www.asco.org/asco/downloads/ CMS_letter_on_clinical_trials_072704_lthd.pdf
14. Centers for Medicare and Medicaid Services: Medicare Modernization Act. http://www.cms.hhs.gov/medicarereform/